The celebrity dermatologist talks about finding her moment of clarity in finding relief for her eczema symptoms and how she ...

Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like SAR444656 and amlitelimab in development.

Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

A South Korean study explored the link between lifestyle decisions beginning in infancy and persistent atopic dermatitis, ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Design The randomized, double-blind, placebo-controlled Phase 1 ...

SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company advancing innovative therapies for high incidence immuno-dermatological ...

"Atopic dermatitis is really just inflamed skin or skin that's been compromised," Hu says ... The itchiness may be more severe at night or when you're feeling relaxed. Over time, the itchy patch of ...

The following is a summary of “Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients ...

Leading biopharmaceutical company Pfizer has unveiled Cibinqo and Staquis, two innovative therapies designed to address eczema across its varying stages, now available in Malaysia. The announcement, ...